|
|
||||||||
AJP - Regulatory, Integrative and Comparative Physiology, Vol 257, Issue 3 528-R535, Copyright © 1989 by American Physiological Society
ARTICLES |
M. Opp, F. Obal Jr and J. M. Krueger
Department of Physiology and Biophysics, University of Tennessee, Memphis 38163.
Interleukin 1 (IL-1), a key mediator of the acute phase response, stimulates hypothalamic corticotropin-releasing factor (CRF) release. The CRF-adrenocorticotrophic hormone (ACTH)-glucocorticoid axis is a feedback for peripheral production and action of IL-1. Effects of intracerebroventricularly administered CRF on rabbit sleepwake activity, brain temperature (Tbr), and behavior and on the central effects of IL-1 [fever and excess non-rapid-eye-movement sleep (NREMS)] were studied. CRF (0.1-1.25 micrograms) dose dependently decreased NREMS and enhanced wakefulness. IL-1-induced excess NREMS was inhibited by CRF. Rapid-eye-movement sleep (REMS) suppressed by IL-1 was partially restored by 0.1 or 0.5 microgram CRF, although CRF itself did not promote REMS. Behavioral effects of intracerebroventricular CRF were relatively small, although 1.25 micrograms abolished ingestion for 3 h, suppressed rearing behavior, and increased sitting behavior. Tbr increased after CRF injection alone. After IL-1 pretreatment, however, 0.1 and 0.5, but not 1.25, micrograms CRF reduced IL-1-induced fever after several hours. These results implicate IL-1-induced CRF release as part of a negative-feedback mechanism attenuating not only peripheral IL-1 actions but also its central effects.
This article has been cited by other articles:
![]() |
E. Szentirmai, L. Kapas, and J. M. Krueger Ghrelin microinjection into forebrain sites induces wakefulness and feeding in rats Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2007; 292(1): R575 - R585. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Schussler, A. Yassouridis, M. Uhr, M. Kluge, J. Weikel, F. Holsboer, and A. Steiger Growth hormone-releasing hormone and corticotropin-releasing hormone enhance non-rapid-eye-movement sleep after sleep deprivation. Am J Physiol Endocrinol Metab, September 1, 2006; 291(3): E549 - E556. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Szentirmai and J. M. Krueger Central administration of neuropeptide Y induces wakefulness in rats Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2006; 291(2): R473 - R480. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Imeri, S. Bianchi, and M. R. Opp Antagonism of corticotropin-releasing hormone alters serotonergic-induced changes in brain temperature, but not sleep, of rats Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2005; 289(4): R1116 - R1123. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Weikel, A. Wichniak, M. Ising, H. Brunner, E. Friess, K. Held, S. Mathias, D. A. Schmid, M. Uhr, and A. Steiger Ghrelin promotes slow-wave sleep in humans Am J Physiol Endocrinol Metab, February 1, 2003; 284(2): E407 - E415. [Abstract] [Full Text] [PDF] |
||||
![]() |
F.-C. Chang and M. R. Opp IL-1 is a mediator of increases in slow-wave sleep induced by CRH receptor blockade Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2000; 279(3): R793 - R802. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Casadevall, E. Saperas, J. Panes, A. Salas, D. C. Anderson, J. R. Malagelada, and J. M. Pique Mechanisms underlying the anti-inflammatory actions of central corticotropin-releasing factor Am J Physiol Gastrointest Liver Physiol, April 1, 1999; 276(4): G1016 - G1026. [Abstract] [Full Text] [PDF] |
||||
![]() |
F.-C. Chang and M. R. Opp Blockade of corticotropin-releasing hormone receptors reduces spontaneous waking in the rat Am J Physiol Regulatory Integrative Comp Physiol, September 1, 1998; 275(3): R793 - R802. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |